Cyp2c79 Rat (R)-lipoic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 Cyp2c79 Rat 1,4-naphthoquinone increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 Cyp2c79 Rat 1-naphthol increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of 1-naphthol CTD PMID:16243959 Cyp2c79 Rat 14,15-EET increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 14 more ... CTD PMID:12675279 Cyp2c79 Rat 17alpha-ethynylestradiol decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat 17beta-estradiol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 Cyp2c79 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 Cyp2c79 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2C79 mRNA CTD PMID:22298810 Cyp2c79 Rat 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Ro 21-5104 results in increased expression of CYP2C8 mRNA CTD PMID:25313206 Cyp2c79 Rat 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 Cyp2c79 Rat 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 Cyp2c79 Rat 4-Hydroxy-N-desmethyltamoxifen decreases activity ISO CYP2C8 (Homo sapiens) 6480464 4-hydroxy-N-desmethyltamoxifen results in decreased activity of CYP2C8 protein CTD PMID:29285606 Cyp2c79 Rat 4-isopropylphenol increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of 4-isopropylphenol CTD PMID:23470418 Cyp2c79 Rat 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime affects binding ISO CYP2C8 (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:15933212 Cyp2c79 Rat 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO CYP2C8 (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:15933212 Cyp2c79 Rat 6-hydroxypaclitaxel increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 6-hydroxytaxol CTD PMID:12401345 Cyp2c79 Rat 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP2C79 mRNA CTD PMID:24780913 Cyp2c79 Rat AB-Fubinaca decreases activity ISO CYP2C8 (Homo sapiens) 6480464 AB-FUBINACA results in decreased activity of CYP2C8 protein CTD PMID:33050066 Cyp2c79 Rat aconitine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Aconitine CTD PMID:21277363 Cyp2c79 Rat aconitine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Gemfibrozil results in decreased activity of CYP2C8 protein] which affects the chemical synthesis of Aconitine metabolite CTD PMID:21277363 Cyp2c79 Rat acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP2C79 mRNA CTD PMID:28959563 Cyp2c79 Rat afimoxifene increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of afimoxifene CTD PMID:29285606 Cyp2c79 Rat afimoxifene decreases activity ISO CYP2C8 (Homo sapiens) 6480464 afimoxifene results in decreased activity of CYP2C8 protein CTD PMID:29285606 Cyp2c79 Rat aflatoxin B1 affects expression ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CYP2C8 protein CTD PMID:20106945 Cyp2c79 Rat aflatoxin B1 decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CYP2C8 gene CTD PMID:27153756 Cyp2c79 Rat aflatoxin B1 decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP2C8 mRNA CTD PMID:22100608 and PMID:27153756 Cyp2c79 Rat all-trans-4-hydroxyretinoic acid increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:10874126 Cyp2c79 Rat all-trans-4-oxoretinoic acid increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:10874126 Cyp2c79 Rat all-trans-retinoic acid affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Tretinoin CTD PMID:15933212 Cyp2c79 Rat all-trans-retinoic acid increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Tretinoin CTD PMID:10874126 Cyp2c79 Rat all-trans-retinoic acid increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Tretinoin CTD PMID:12464242 Cyp2c79 Rat almotriptan decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of almotriptan CTD PMID:12642466 Cyp2c79 Rat aminophenazone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] and Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 Cyp2c79 Rat aminophenazone decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of Aminopyrine CTD PMID:26763401 Cyp2c79 Rat amiodarone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Amiodarone results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat amiodarone decreases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 Cyp2c79 Rat amiodarone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Amiodarone results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat amiodarone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Amiodarone CTD PMID:15716363 Cyp2c79 Rat amodiaquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [5-bromotryptamine analog results in decreased activity of CYP2C8 protein] which results in decreased metabolism of Amodiaquine more ... CTD PMID:15771232 more ... Cyp2c79 Rat amodiaquine increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased susceptibility to Amodiaquine CTD PMID:31629065 Cyp2c79 Rat amodiaquine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Amodiaquine CTD PMID:15155557 more ... Cyp2c79 Rat amodiaquine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Amodiaquine CTD PMID:12920490 and PMID:15626586 Cyp2c79 Rat amoxicillin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 Cyp2c79 Rat amoxicillin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin results in decreased activity of CYP2C8 protein CTD PMID:26763401 Cyp2c79 Rat arachidonic acid increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 Cyp2c79 Rat Aroclor 1254 increases expression ISO CYP2C8 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2C8 mRNA CTD PMID:17851650 Cyp2c79 Rat Auriculasin increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of auriculasin CTD PMID:31515991 Cyp2c79 Rat Auriculasin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Quercetin inhibits the reaction [CYP2C8 protein results in increased metabolism of auriculasin] CTD PMID:31515991 Cyp2c79 Rat benzo[a]pyrene decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP2C8 mRNA CTD PMID:32234424 Cyp2c79 Rat bezafibrate decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Bezafibrate results in decreased expression of CYP2C8 protein CTD PMID:29960002 Cyp2c79 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Diethylhexyl Phthalate results in increased expression of CYP2C8] which results in increased metabolism of and results in decreased activity of Doxorubicin and Diethylhexyl Phthalate promotes the reaction [AHR protein binds to CYP2C8 promoter] CTD PMID:34801851 Cyp2c79 Rat bis(2-ethylhexyl) phthalate increases expression ISO CYP2C8 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CYP2C8 mRNA CTD PMID:34801851 Cyp2c79 Rat bisphenol A increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bisphenol A and CYP2C8 protein results in increased hydroxylation of bisphenol A metabolite CTD PMID:23470418 Cyp2c79 Rat bisphenol A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 bisphenol A results in decreased activity of CYP2C8 protein CTD PMID:10784435 Cyp2c79 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2C8 mRNA CTD PMID:25181051 Cyp2c79 Rat bisphenol A increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of bisphenol A and CYP2C8 protein results in increased glutathionylation of bisphenol A metabolite CTD PMID:23470418 Cyp2c79 Rat bisphenol F increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of 4 and 4'-bisphenol F CTD PMID:23470418 Cyp2c79 Rat bisphenol F increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of 4 and 4'-bisphenol F CTD PMID:23470418 Cyp2c79 Rat bromfenac increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bromfenac CTD PMID:31815452 Cyp2c79 Rat Bufuralol increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bufuralol CTD PMID:9429232 Cyp2c79 Rat buprenorphine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Buprenorphine CTD PMID:16010532 Cyp2c79 Rat butyric acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Butyric Acid results in increased expression of CYP2C8 mRNA CTD PMID:30439556 Cyp2c79 Rat camptothecin decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Camptothecin results in decreased expression of CYP2C8 mRNA CTD PMID:29356861 Cyp2c79 Rat camptothecin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA] CTD PMID:29356861 Cyp2c79 Rat Candesartan cilexetil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 candesartan cilexetil results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat carbamazepine increases expression ISO CYP2C8 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP2C8 mRNA CTD PMID:17112801 Cyp2c79 Rat carbamazepine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Carbamazepine CTD PMID:15286053 and PMID:15915352 Cyp2c79 Rat carbamazepine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Carbamazepine CTD PMID:12464242 Cyp2c79 Rat carbamazepine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the metabolism of Carbamazepine] CTD PMID:15915352 Cyp2c79 Rat carbamazepine-10,11-epoxide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide] CTD PMID:15915352 Cyp2c79 Rat carbamazepine-10,11-epoxide affects chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide CTD PMID:15915352 Cyp2c79 Rat carfentanil increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of carfentanil CTD PMID:33652071 Cyp2c79 Rat cerivastatin affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene mutant form affects the susceptibility to cerivastatin CTD PMID:15365880 Cyp2c79 Rat cerivastatin increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of cerivastatin CTD PMID:12464242 more ... Cyp2c79 Rat chenodeoxycholic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in decreased expression of CYP2C8 mRNA CTD PMID:27174168 Cyp2c79 Rat chenodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat chloroquine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 polymorphism affects the metabolism of Chloroquine and CYP2C8 protein affects the metabolism of Chloroquine CTD PMID:12920490 and PMID:19560616 Cyp2c79 Rat chloroquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine and Quercetin inhibits the reaction [[CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine] CTD PMID:12756207 and PMID:12967198 Cyp2c79 Rat chloroquine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Chloroquine CTD PMID:17286541 Cyp2c79 Rat chlorpromazine decreases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 Cyp2c79 Rat cinitapride increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of cinitapride CTD PMID:17437965 Cyp2c79 Rat clofibric acid increases activity ISO CYP2C8 (Homo sapiens) 6480464 Clofibric Acid results in increased activity of CYP2C8 protein CTD PMID:15771232 Cyp2c79 Rat clofibric acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Clofibric Acid results in increased expression of CYP2C8 mRNA and Clofibric Acid results in increased expression of CYP2C8 protein CTD PMID:15771232 Cyp2c79 Rat Clofop increases activity ISO CYP2C8 (Homo sapiens) 6480464 fenofibric acid results in increased activity of CYP2C8 protein CTD PMID:15771232 Cyp2c79 Rat Clofop increases expression ISO CYP2C8 (Homo sapiens) 6480464 fenofibric acid results in increased expression of CYP2C8 mRNA and fenofibric acid results in increased expression of CYP2C8 protein CTD PMID:15771232 Cyp2c79 Rat clopidogrel multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite CTD PMID:19170597 Cyp2c79 Rat clotrimazole decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Clotrimazole results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:33775687 Cyp2c79 Rat clozapine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Clozapine CTD PMID:18809730 and PMID:27320963 Cyp2c79 Rat Clozapine N-oxide increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of clozapine N-oxide CTD PMID:27320963 Cyp2c79 Rat cocaine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Cocaine results in decreased expression of CYP2C8 mRNA and Cocaine results in decreased expression of CYP2C8 protein CTD PMID:16188404 Cyp2c79 Rat cumene hydroperoxide affects oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 Cyp2c79 Rat cyclophosphamide increases activity ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 results in increased activity of Cyclophosphamide CTD PMID:9241661 Cyp2c79 Rat cyclosporin A decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 Cyp2c79 Rat cyclosporin A affects oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the oxidation of Cyclosporine CTD PMID:7870052 Cyp2c79 Rat cylindrospermopsin decreases expression ISO CYP2C8 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of CYP2C8 mRNA CTD PMID:30905859 Cyp2c79 Rat cypermethrin increases expression ISO CYP2C8 (Homo sapiens) 6480464 cypermethrin results in increased expression of CYP2C8 mRNA CTD PMID:22310298 Cyp2c79 Rat dabrafenib decreases activity ISO CYP2C8 (Homo sapiens) 6480464 dabrafenib results in decreased activity of CYP2C8 protein CTD PMID:34780725 Cyp2c79 Rat dapsone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Dapsone CTD PMID:17286541 Cyp2c79 Rat deoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat Desethylchloroquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine and Quercetin inhibits the reaction [[CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine] CTD PMID:12756207 and PMID:12967198 Cyp2c79 Rat dexamethasone affects binding ISO CYP2C8 (Homo sapiens) 6480464 [Dexamethasone binds to NR3C1 protein] which binds to CYP2C8 promoter CTD PMID:15933212 Cyp2c79 Rat dexamethasone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CYP2C8 mRNA CTD PMID:15933212 and PMID:19118567 Cyp2c79 Rat Dihydrotanshinone I decreases activity ISO CYP2C8 (Homo sapiens) 6480464 dihydrotanshinone I results in decreased activity of CYP2C8 protein CTD PMID:29689254 Cyp2c79 Rat diosmetin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 diosmetin results in decreased activity of CYP2C8 protein CTD PMID:28867436 Cyp2c79 Rat domperidone increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 Cyp2c79 Rat doxorubicin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Diethylhexyl Phthalate results in increased expression of CYP2C8] which results in increased metabolism of and results in decreased activity of Doxorubicin CTD PMID:34801851 Cyp2c79 Rat felbamate increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Felbamate CTD PMID:35786679 Cyp2c79 Rat felodipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Felodipine results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:28119166 Cyp2c79 Rat felodipine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Felodipine inhibits the reaction [CYP2C8 protein results in increased metabolism of Amodiaquine] CTD PMID:28119166 Cyp2c79 Rat fenitrothion decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fenitrothion results in decreased activity of CYP2C8 protein CTD PMID:20183062 Cyp2c79 Rat fenofibrate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat fenofibrate affects expression ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate affects the expression of CYP2C8 protein CTD PMID:29960002 Cyp2c79 Rat fenofibrate increases expression ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate results in increased expression of CYP2C8 mRNA CTD PMID:25572481 Cyp2c79 Rat fenvalerate increases expression ISO CYP2C8 (Homo sapiens) 6480464 fenvalerate results in increased expression of CYP2C8 mRNA CTD PMID:22310298 Cyp2c79 Rat fipronil increases expression ISO CYP2C8 (Homo sapiens) 6480464 fipronil results in increased expression of CYP2C8 mRNA CTD PMID:27091632 Cyp2c79 Rat fipronil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C8 mRNA CTD PMID:27091632 Cyp2c79 Rat fluoxetine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fluoxetine results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat fluoxetine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Fluoxetine results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat furan decreases expression EXP 6480464 furan results in decreased expression of CYP2C79 mRNA CTD PMID:26194646 Cyp2c79 Rat gemfibrozil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Gemfibrozil co-treated with Amodiaquine] results in decreased activity of CYP2C8 protein more ... CTD PMID:15771232 more ... Cyp2c79 Rat gemfibrozil increases expression ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil results in increased expression of CYP2C8 mRNA CTD PMID:15771232 Cyp2c79 Rat gemfibrozil decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil results in decreased expression of CYP2C8 protein CTD PMID:15771232 and PMID:29960002 Cyp2c79 Rat gemfibrozil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil metabolite results in decreased activity of CYP2C8 protein and Gemfibrozil results in decreased activity of CYP2C8 protein CTD PMID:15771232 and PMID:16042675 Cyp2c79 Rat glutathione multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac CTD PMID:24246759 Cyp2c79 Rat glycochenodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat glycocholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat glycodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat glyoxal multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of and results in increased susceptibility to sudoxicam] which results in increased chemical synthesis of Glyoxal CTD PMID:33253783 Cyp2c79 Rat Hypaconitine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of hypaconitine CTD PMID:21550385 Cyp2c79 Rat ibuprofen affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism affects the metabolism of Ibuprofen CTD PMID:15606441 Cyp2c79 Rat ibuprofen increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism results in increased metabolism of Ibuprofen CTD PMID:18694831 Cyp2c79 Rat ibuprofen decreases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism results in decreased metabolism of Ibuprofen CTD PMID:15289789 Cyp2c79 Rat ifosfamide increases activity ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 results in increased activity of Ifosfamide CTD PMID:9241661 Cyp2c79 Rat irbesartan decreases activity ISO CYP2C8 (Homo sapiens) 6480464 irbesartan results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat isoniazide decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Isoniazid results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat isoniazide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Isoniazid results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat ketoconazole decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP2C8 protein CTD PMID:14709627 and PMID:15601807 Cyp2c79 Rat ketoconazole multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 Cyp2c79 Rat lansoprazole affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Lansoprazole CTD PMID:7870052 Cyp2c79 Rat lansoprazole increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Lansoprazole CTD PMID:8627562 Cyp2c79 Rat Licochalcone A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 licochalcone A results in decreased activity of CYP2C8 protein CTD PMID:26100226 Cyp2c79 Rat lipoic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 Cyp2c79 Rat loratadine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Loratadine results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat lovastatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Lovastatin results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat masitinib increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of masitinib CTD PMID:36048877 Cyp2c79 Rat medroxyprogesterone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Medroxyprogesterone results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat MeIQx decreases expression ISO CYP2C8 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 Cyp2c79 Rat methoxychlor decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 and PMID:12433799 Cyp2c79 Rat methyltestosterone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of CYP2C8 mRNA CTD PMID:27344345 Cyp2c79 Rat mometasone furoate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Mometasone Furoate results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat montelukast decreases activity ISO CYP2C8 (Homo sapiens) 6480464 montelukast results in decreased activity of CYP2C8 protein CTD PMID:15601807 more ... Cyp2c79 Rat montelukast increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of montelukast CTD PMID:19309152 Cyp2c79 Rat mycophenolic acid increases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased methylation of Mycophenolic Acid CTD PMID:15570183 Cyp2c79 Rat N,N-diethyl-m-toluamide increases expression ISO CYP2C8 (Homo sapiens) 6480464 DEET results in increased expression of CYP2C8 mRNA CTD PMID:27091632 Cyp2c79 Rat N,N-diethyl-m-toluamide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C8 mRNA CTD PMID:27091632 Cyp2c79 Rat N-desmethylclozapine increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 Cyp2c79 Rat NADP zwitterion multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:24120545 Cyp2c79 Rat NADP(+) multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:24120545 Cyp2c79 Rat naphthalene increases expression ISO CYP2C8 (Homo sapiens) 6480464 naphthalene results in increased expression of CYP2C8 mRNA CTD PMID:20500019 Cyp2c79 Rat Neferine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of and results in decreased methylation of neferine CTD PMID:25451576 Cyp2c79 Rat Neferine increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of neferine metabolite CTD PMID:25451576 Cyp2c79 Rat nicardipine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Nicardipine CTD PMID:15863898 Cyp2c79 Rat nicardipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nicardipine results in decreased activity of CYP2C8 protein CTD PMID:15863898 Cyp2c79 Rat nifedipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nifedipine results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat nortriptyline decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nortriptyline results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat nortriptyline multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Nortriptyline results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat O-methyleugenol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP2C8 mRNA CTD PMID:32234424 Cyp2c79 Rat obeticholic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP2C8 mRNA CTD PMID:27939613 Cyp2c79 Rat oxybutynin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 oxybutynin results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat paclitaxel increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Paclitaxel CTD PMID:12401345 more ... Cyp2c79 Rat paclitaxel increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 mRNA results in increased susceptibility to Paclitaxel CTD PMID:15239142 Cyp2c79 Rat paclitaxel increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Paclitaxel CTD PMID:21964418 Cyp2c79 Rat paclitaxel affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Paclitaxel CTD PMID:15901749 and PMID:15933212 Cyp2c79 Rat paclitaxel affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene SNP affects the susceptibility to Paclitaxel CTD PMID:27736846 Cyp2c79 Rat paclitaxel increases oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of Paclitaxel CTD PMID:17478480 Cyp2c79 Rat paclitaxel multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Cyclohexenes analog inhibits the reaction [CYP2C8 protein results in increased metabolism of Paclitaxel] more ... CTD PMID:20452209 more ... Cyp2c79 Rat paracetamol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP2C8 mRNA CTD PMID:29067470 Cyp2c79 Rat paracetamol multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat parathion affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Parathion CTD PMID:12669189 Cyp2c79 Rat pazopanib increases expression ISO CYP2C8 (Homo sapiens) 6480464 pazopanib results in increased expression of CYP2C8 mRNA CTD PMID:29356861 Cyp2c79 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP2C8 protein results in increased hydroxylation of Paclitaxel] CTD PMID:21964418 Cyp2c79 Rat perfluorooctane-1-sulfonic acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2C8 mRNA CTD PMID:27153767 and PMID:32588087 Cyp2c79 Rat perfluorooctanoic acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 perfluorooctanoic acid results in increased expression of CYP2C8 mRNA CTD PMID:38513818 Cyp2c79 Rat phencyclidine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Phencyclidine CTD PMID:16782764 Cyp2c79 Rat Phenelzine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Phenelzine results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat Phenelzine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Phenelzine results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat phenobarbital increases expression ISO CYP2C8 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP2C29 protein more ... CTD PMID:19118567 more ... Cyp2c79 Rat pimecrolimus multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 pimecrolimus inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA] CTD PMID:29356861 Cyp2c79 Rat pioglitazone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil inhibits the reaction [CYP2C8 protein affects the metabolism of pioglitazone] CTD PMID:15900286 Cyp2c79 Rat pioglitazone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Pioglitazone results in increased expression of CYP2C8 mRNA CTD PMID:31233785 Cyp2c79 Rat pioglitazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 pioglitazone results in decreased activity of CYP2C8 protein CTD PMID:12642470 Cyp2c79 Rat pioglitazone affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of pioglitazone CTD PMID:15900286 Cyp2c79 Rat piperacillin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Piperacillin results in decreased activity of CYP2C8 protein CTD PMID:26763401 Cyp2c79 Rat piperacillin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 Cyp2c79 Rat pirinixic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 pirinixic acid results in decreased expression of CYP2C8 protein CTD PMID:29960002 Cyp2c79 Rat probenecid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide] and Probenecid promotes the reaction [CYP2C8 protein affects the metabolism of Carbamazepine] CTD PMID:15915352 Cyp2c79 Rat progesterone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP2C8 mRNA CTD PMID:22837389 Cyp2c79 Rat quercetin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Quercetin results in decreased activity of CYP2C8 protein CTD PMID:15155557 more ... Cyp2c79 Rat quercetin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Quercetin results in decreased activity of CYP2C8 protein] which results in decreased degradation of vanoxerine more ... CTD PMID:11502731 more ... Cyp2c79 Rat raloxifene decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat resveratrol decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Resveratrol results in decreased activity of CYP2C8 protein CTD PMID:30394306 Cyp2c79 Rat rifampicin increases expression ISO CYP2C8 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP2C8 mRNA and Rifampin results in increased expression of CYP2C8 protein CTD PMID:12040753 more ... Cyp2c79 Rat rifampicin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein more ... CTD PMID:29356861 and PMID:31629065 Cyp2c79 Rat rifampicin increases activity ISO CYP2C8 (Homo sapiens) 6480464 Rifampin results in increased activity of CYP2C8 protein CTD PMID:15771232 and PMID:22126990 Cyp2c79 Rat rifampicin affects binding ISO CYP2C8 (Homo sapiens) 6480464 [Rifampin binds to NR1I2 protein] which binds to CYP2C8 promoter CTD PMID:15933212 Cyp2c79 Rat ritonavir decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ritonavir results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat Salmeterol xinafoate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Salmeterol Xinafoate results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat Salvianolic acid A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 salvianolic acid A results in decreased activity of CYP2C8 protein CTD PMID:29689254 Cyp2c79 Rat Salvianolic acid C decreases activity ISO CYP2C8 (Homo sapiens) 6480464 salvianolic acid C results in decreased activity of CYP2C8 protein CTD PMID:29689254 Cyp2c79 Rat satraplatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 satraplatin results in decreased activity of CYP2C8 protein CTD PMID:24882083 Cyp2c79 Rat Senkirkine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 senkirkine results in decreased expression of CYP2C8 mRNA CTD PMID:26100227 Cyp2c79 Rat silibinin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Silybin results in decreased activity of CYP2C8 protein CTD PMID:28457856 Cyp2c79 Rat silicon dioxide decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP2C8 mRNA CTD PMID:25895662 Cyp2c79 Rat simvastatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Simvastatin results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat sodium arsenite decreases expression ISO CYP2C8 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP2C8 mRNA CTD PMID:29301061 and PMID:34032870 Cyp2c79 Rat sorafenib decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Sorafenib metabolite results in decreased activity of CYP2C8 protein and Sorafenib results in decreased activity of CYP2C8 protein CTD PMID:33556367 Cyp2c79 Rat spironolactone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Spironolactone results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat sporidesmin A affects expression ISO CYP2C8 (Homo sapiens) 6480464 sporidesmin affects the expression of CYP2C8 mRNA CTD PMID:28193462 Cyp2c79 Rat sporidesmin A multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 MIR21 mRNA affects the reaction [sporidesmin affects the expression of CYP2C8 mRNA] CTD PMID:28193462 Cyp2c79 Rat Sudan I increases oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 Cyp2c79 Rat sulfadiazine increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Sulfadiazine CTD PMID:15843491 Cyp2c79 Rat sulfinpyrazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Sulfinpyrazone results in decreased activity of CYP2C8 protein CTD PMID:12464242 Cyp2c79 Rat Sunset Yellow FCF multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Cyp2c79 Rat tamoxifen decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Tamoxifen results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:29285606 Cyp2c79 Rat tamoxifen increases activity ISO CYP2C8 (Homo sapiens) 6480464 Tamoxifen metabolite results in increased activity of CYP2C8 protein CTD PMID:29285606 Cyp2c79 Rat Tanshinone I decreases activity ISO CYP2C8 (Homo sapiens) 6480464 tanshinone results in decreased activity of CYP2C8 protein CTD PMID:29689254 Cyp2c79 Rat tetrachloroethene increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 Cyp2c79 Rat Thiocoraline affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of thiocoraline CTD PMID:15122071 Cyp2c79 Rat thyroxine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Thyroxine results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat ticlopidine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite CTD PMID:19170597 Cyp2c79 Rat tolbutamide increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Tolbutamide CTD PMID:15843491 Cyp2c79 Rat torasemide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Torsemide inhibits the reaction [Amiodarone results in decreased activity of CYP2C8 protein] more ... CTD PMID:15304522 Cyp2c79 Rat torasemide increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Torsemide CTD PMID:15304522 Cyp2c79 Rat trans-cinnamic acid decreases activity ISO CYP2C8 (Homo sapiens) 6480464 cinnamic acid analog results in decreased activity of CYP2C8 protein CTD PMID:15072549 Cyp2c79 Rat tranylcypromine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 Cyp2c79 Rat triflumuron increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of triflumuron CTD PMID:31082524 Cyp2c79 Rat trimethoprim increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Trimethoprim CTD PMID:12464242 Cyp2c79 Rat trimethoprim decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Trimethoprim results in decreased activity of CYP2C8 protein CTD PMID:15570183 Cyp2c79 Rat Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2C8 protein CTD PMID:33600922 Cyp2c79 Rat troglitazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 troglitazone results in decreased activity of CYP2C8 protein CTD PMID:12642470 Cyp2c79 Rat troglitazone increases expression ISO CYP2C8 (Homo sapiens) 6480464 troglitazone results in increased expression of CYP2C8 mRNA CTD PMID:25572481 Cyp2c79 Rat troglitazone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of troglitazone CTD PMID:19356091 Cyp2c79 Rat tryptamines multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Tryptamines analog results in decreased activity of CYP2C8 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 Cyp2c79 Rat tryptamines decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Tryptamines analog results in decreased activity of CYP2C8 protein CTD PMID:26599973 Cyp2c79 Rat valproic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP2C8 mRNA CTD PMID:29501571 Cyp2c79 Rat vanoxerine dihydrochloride decreases degradation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased degradation of vanoxerine CTD PMID:11502731 Cyp2c79 Rat vanoxerine dihydrochloride multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Quercetin results in decreased activity of CYP2C8 protein] which results in decreased degradation of vanoxerine CTD PMID:11502731 Cyp2c79 Rat verapamil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Cyp2c79 Rat verapamil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP2C8 protein CTD PMID:15304522 Cyp2c79 Rat vincristine increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene SNP results in increased susceptibility to Vincristine CTD PMID:21245421 Cyp2c79 Rat warfarin affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 polymorphism affects the susceptibility to Warfarin CTD PMID:34382722 Cyp2c79 Rat zafirlukast decreases activity ISO CYP2C8 (Homo sapiens) 6480464 zafirlukast results in decreased activity of CYP2C8 protein CTD PMID:15601807 Cyp2c79 Rat zopiclone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of zopiclone CTD PMID:12464242